Wells Fargo Maintains Overweight on The Vita Coco Co, Lowers Price Target to $65
Wells Fargo analyst Chris Carey maintains The Vita Coco Co (NASDAQ:COCO) with a Overweight and lowers the price target from $85 to $65.
Stocks · News reference
Oppenheimer Initiates Coverage On The Vita Coco Co with Outperform Rating, Announces Price Target of $70
Oppenheimer analyst Rupesh Parikh initiates coverage on The Vita Coco Co (NASDAQ:COCO) with a Outperform rating and announces Price Target of $70.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.
MNST's International Sales Surge 35%: Is Global Expansion Paying Off?
Monster Beverage's international sales jumped 34.6% to $1.16B in Q2 2026, now representing 46% of total sales. Strong growth in EMEA (27.2%), Asia-Pacific (35.7%), and Latin America (56.1%) is driven by product innovation, cooler placements, and Coca-Cola bottler partnerships. However, lower overseas margins and inflation in aluminum, freight, and fuel pose challenges. The stock trades at a premium 36.59X forward P/E, well above the industry average of 19.32X.